Chronic escitalopram treatment caused dissociative adaptation in serotonin (5‑HT) 2C receptor antagonist‑induced effects in REM sleep, wake and theta wave activity

Kostyalik, Diána and Kátai, Zita and Vas, Szilvia and Pap, Dorottya and Petschner, Péter and Molnár, Eszter and Gyertyán, István and Kalmár, Lajos and Tóthfalusi, László and Bagdy, György (2014) Chronic escitalopram treatment caused dissociative adaptation in serotonin (5‑HT) 2C receptor antagonist‑induced effects in REM sleep, wake and theta wave activity. EXPERIMENTAL BRAIN RESEARCH, 232 (3). pp. 935-946. ISSN 0014-4819

Text art%3A10.1007%2Fs00221-013-3806-8.pdf Restricted to Registered users only Download (526kB) | Request a copy

Abstract

Several multi-target drugs used in treating psychiatric disorders, such as antidepressants (e.g. agomelatine, trazodone, nefazodone, amitriptyline, mirtazapine, mianserin, fluoxetine) or most atypical antipsychotics, have 5-hydroxytryptamine 2C (5-HT2C) receptor-blocking property. Adaptive changes in 5-HT2C receptor-mediated functions are suggested to contribute to therapeutic effects of selective serotonin reuptake inhibitor (SSRI) antidepressants after weeks of treatment, at least in part. Beyond the mediation of anxiety and other functions, 5-HT2C receptors are involved in sleep regulation. Anxiety-related adaptive changes caused by antidepressants have been studied extensively, although sleep- and electroencephalography (EEG)-related functional studies are still lacking. The aim of this study was to investigate the effects of chronic SSRI treatment on 5-HT2C receptor antagonist-induced functions in different vigilance stages and on quantitative EEG (Q-EEG) spectra. Rats were treated with a single dose of the selective 5-HT2C receptor antagonist SB-24208(1 mg/kg, i.p.) or vehicle at the beginning of passive phase following a 20-day-long SSRI (escitalopram; 10 mg/ kg/day, osmotic minipump) or VEHICLE pretreatment. Fronto-parietal electroencephalogram, electromyogram and motility were recorded during the first 3 h of passive phase. We found that the chronic escitalopram pretreatment attenuated the SB-242084-caused suppression in rapid eye movement sleep (REMS). On the contrary, the 5-HT2C receptor antagonist-induced elevations in passive wake and theta (5–9 H z) power density during active wake and REMS were not affected by the SSRI. In conclusion, attenuation in certain, but not all vigilance- and Q-EEG-related functions induced by the 5-HT2C receptor antagonist, suggests dissociation in 5-HT2C receptor adaptation

Actions (login required)

Edit Item